Ph: 16802706
Your browser version may not work well with NCBI's Web applications. More information here...
1: Adv Exp Med Biol. 2006;576:77-93; discussion 361-3.
Related Articles, Links

Canavan disease: studies on the knockout mouse.

Matalon R, Michals-Matalon K, Surendran S, Tyring SK.

Department of Pediatrics, University of Texas Medical Branch, Galveston, TX 77555, USA. rmatalon@utmb.edu

Canavan disease (CD) is an autosomal recessive disorder, characterized by spongy degeneration of the brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA. Clinically, patients with CD have macrocephaly, mental retardation and hypotonia. A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated NAA. Molecular studies of the mouse brain showed abnormal expression of multiple genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology in the CD mouse.

Publication Types:
Review

PMID: 16802706 [PubMed - indexed for MEDLINE]

You are viewing a mobilized version of this site...
View original page here

How do you rate mobile version of this page?

Mobilized by Mowser Mowser